"Bezafibrate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW DENSITY LIPOPROTEINS and increases HIGH DENSITY LIPOPROTEINS.
| Descriptor ID |
D001629
|
| MeSH Number(s) |
D02.065.277.067 D02.241.081.114.968.500.249 D02.241.223.100.100.120 D02.241.223.100.200.249 D02.355.726.305.249 D02.455.426.559.389.127.085.101 D02.455.426.559.389.127.250.249 D02.455.426.559.389.657.654.305.249
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bezafibrate".
Below are MeSH descriptors whose meaning is more specific than "Bezafibrate".
This graph shows the total number of publications written about "Bezafibrate" by people in this website by year, and whether "Bezafibrate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2018 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Bezafibrate" by people in Profiles.
-
Antipruritic effect of bezafibrate and serum autotaxin measures in patients with primary biliary cholangitis. Gut. 2019 10; 68(10):1902-1903.
-
Work in Progress: Drugs in Development. Clin Liver Dis. 2018 08; 22(3):501-515.
-
Management of Chronic Hepatic Itch. Dermatol Clin. 2018 Jul; 36(3):293-300.
-
On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis. 2009 Aug; 205(2):413-9.